Discover our latest financial performance announcement and search for historical quarterly results materials
2023 Q2 Financial Results - Results Summary in English 2023 Q2 Financial Results - Results Summary in Mandarin 2023 Q1 2023 Q1 Financial Results - Press Release 2023 Q1 Financial Results - Consolidated Financial Report (IFRS) 2023 Q1 Financial Results - Results Summary in English 2023 Q1 Fi...
Quarterly Results 2024 2023 2022 2021 2020 2019 2018
You should not view adjusted results on a stand-alone basis or as a substitute for results under IFRS, or as being comparable to results reported or forecasted by other companies. This release provides a summary of the results and...
Quarterly Results Presentations Japanese Tweet Font size S M L Print FY2025/03 Q2 Earnings (October 29, 2024) Presentation(691KB) Earnings Releases(252KB) Historical Financial Data(98KB) Historical Financial Data(786KB) Webcast - Until January 28,2025 Q1 Earnings (July 30, 2024) Press Rel...
Finnish forestry group Stora Enso has seen its pessimistic earnings forecasts come true: the company said in its third-quarter results for 2023 that it had faced deteriorating market conditions and price pressure in all segments, including its packaging businesses. For the third quarter of the 2023...
In order to enable investors to have a more comprehensive and deeper understanding of the Company, the Company plans to convene a results presentation through online interaction from 9:00 a.m. to 10:00 a.m. on 31 October 2023 to communicate with investors on commonly concerned questions. Mr...
Find out how we are performing. View our quarterly, half year and annual financial results and access our archive from 2002.
prices and availability of electricity and natural gas in wholesale markets; market perception of the energy industry and the Evergy Companies; the impact of future Coronavirus (COVID-19) variants on, among other things, sales, results of operations, financial condition, liquidity a...
Champions Oncology, Inc., a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, announced its financial results for its third quarter of fiscal 2023, ended Janua